DETX Spikes on 7.2x Volume Surge as Deep-Discount Security Stock Wakes Up
DETX volume surged to 7.2x its 20-day average, but negative PBR (-1.62x) and EV/EBITDA (-1.8x) flag balance-sheet risk in this unclassified security-detection micro-cap.
signal:DETX:2026-08-10 DETX Spikes on 7.2x Volume Surge as Deep-Discount Security Stock Wakes Up
Trading volume in DETX exploded to 7.2x its 20-day average, a sharp enough dislocation to pull the security-detection micro-cap onto the radar of momentum-driven flow. The thesis here is straightforward: a stock priced at a steep discount to its book value is suddenly seeing real participation, and that combination of neglected valuation plus a volume shock is exactly the setup worth tracking rather than chasing.
The company sits in an unclassified corner of the market, meaning it lacks the sector-level benchmarks that make comparisons easy — which makes the volume signal itself, rather than peer multiples, the most concrete data point on offer right now.
Key Facts
| Stock name | DETX |
|---|---|
| Ticker | DETX |
| Market | NASDAQ |
| Sector | Unclassified |
| Volume (x average) | 7.2x |
| Signal price | $3.67 |
The business develops and commercializes security detection technology across Canada, the United States, and international markets, operating through its HEXWAVE and Contract segments. Its flagship HEXWAVE system is a walk-through scanner designed to detect concealed metallic and non-metallic weapons, complemented by body scanners and footwear screeners built for aviation checkpoints and an open-architecture platform for airport security. Customers span schools, hospitals, airports, government offices, transit systems, and large public venues, positioning the company as a niche supplier in the physical security screening space.
Recent Analyst Coverage
External analyst opinions (not investment advice): (2021-12-01)
| Strong Buy | 1 |
|---|---|
| Buy | 3 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
Peer Companies
BCO, GEO, CXW, KSCP, SCAN.V
Risk Factors
The valuation picture cuts both ways. A price-to-book ratio of -1.62x and an EV/EBITDA of -1.8x are not classic "cheap" signals — both are negative because book equity and EBITDA are themselves negative, which points to balance-sheet strain and unprofitable operations rather than simple undervaluation. That should temper any read of the volume surge as a pure value re-rating.
Earnings execution has also been shaky: the most recently reported quarter (period ended 2019-12-31) missed estimates by -12.8%, posting an actual EPS of -83.7 against a forecast of -74.1981. The dated nature of that print is itself a flag — investors watching this name should confirm whether more recent quarterly results are available before drawing conclusions from it.
On the macro side, conditions are broadly calm but not without texture: the VIX sits at 15.5, a normal-range reading, while the 10-year Treasury yield has drifted up 9 basis points over the past month to 4.70% in a sideways pattern — a mild headwind for smaller, low-profitability names sensitive to funding costs. High-yield credit spreads (OAS) are stable at 2.70%, suggesting no acute stress in risk appetite, but a thinly traded micro-cap like this would likely be among the first to feel any widening. The stock's proximity to the August 13 options expiration and the seasonal MSCI quarterly rebalance add potential for mechanical volatility unrelated to fundamentals.
Recent Disclosures
No disclosures in the past 30 days.
Recent News
No notable news in the past 30 days.
Pre-Trade Checklist
| Business & competitive edge understood | ✅ Company profile summarized above |
|---|---|
| Leading sector | ⚠️ Not flagged as a leading sector |
| Good news already priced in? | ✅ PBR -1.62배 (자산가치 대비 저평가) |
| Stop-loss / take-profit set | ✅ Stop-loss -10% / first take-profit +20% set in advance |
| Exit plan if wrong | ✅ 10% trailing stop from peak; setup auto-invalidated on a break below key support |
Trade Levels
| Signal price | $3.67 |
|---|---|
| Stop-loss | $3.30 (-10% from signal price) |
| First take-profit | $4.40 (+20% from signal price) |
| Trailing stop | 10% from peak |
| Invalidation | Close back below key support ($3.46) |
This is a name to watch rather than chase: the signal price sits at $3.67, with a defined stop-loss at $3.30 (-10%) and an initial take-profit target at $4.40 (+20%), after which a 10% trailing stop from any new peak would apply. A close back below the $3.46 support level would undercut the setup's premise entirely. Given the negative earnings and valuation backdrop underlying the volume spike, conviction here should stay conditional on price holding above that support line rather than on the surge alone.